News

Thermo Fisher Scientific and Patheon together announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon at a price of $7.2 billion. Thermo Fisher…
Read More...

Upon the approval from the FDA to sell vadadustat to Fresenius Medical Care dialysis clinics in the US, Akebia Therapeutics and Vifor Pharma Group entered into an exclusive license…
Read More...

Patheon announced that with an investment of $26 million it has updated sterile Pharmaceutical Development Services (PDS) suites at its Greenville, NC manufacturing site. The PDS Suites…
Read More...

DelMar Pharmaceuticals  announced that it has signed collaboration agreement with PRA Health Sciences for company's Phase 3 trial of VAL-083 in recurrent glioblastoma multiforme (GBM).…
Read More...

Jose Carmona (Pepe) has been appointed as CFO of Radius health. He will succeed to Nick Harvey, who will continue as an advisor to the Company in the areas of Finance, Business…
Read More...

Biogen has acquired Remedy Pharmaceuticals’ Phase 3 candidate CIRARA (intravenous glyburide). The target indication for CIRARA is large hemispheric infarction (LHI), a severe form of…
Read More...

Siemens Healthineers announced its strategic partnership with Imricor medical system to develop an integrated solution that combines the clinical benefits of real-time MRI scans with…
Read More...

Pfizer announced that its 13-valent Pneumococcal Conjugate (PCV13) Vaccine has been selected for immunization program of India’s babies in select states. Results of the…
Read More...

Merck announced its collaboration with Stelis Biopharma to open its first joint Process Scale-Up Lab at the Stelis Biopharma R&D Facility in the Jigani industrial estate, Bangalore.…
Read More...

FDA announced the authorization of Flourish Pediatric Esophageal Atresia Anastomosis to treat esophageal atresia in Infants. Flourish Pediatric Esophageal Atresia Anastomosis is a…
Read More...

Norgine B.V. and Merus Labs International announced that they have entered into a merger agreement under which Norgine will acquire all of the issued and outstanding common shares of…
Read More...

NantCell and NantKwest announced that the FDA has authorized NANT Cancer Vaccine for clinical trial enrollment (ClinicalTrials.gov NCT03136406). The NANT Cancer Vaccine is the first…
Read More...

NantHealth announced that Dr. Sandeep Reddy has been appointed as Chief Medical Officer. He will be responsible for overseeing education, outreach, clinical development programs, and…
Read More...

Novocure announced that it has elected Martin J. Madden to its Board of Directors in the meeting of shareholders. Mr. Madden recently retired after a 30-year career in medical device…
Read More...

Avita Medical Limited filed an IPR (Inter Partes Review) petition against US Patent No. 9,610,430 owned by Renovacare Sciences and request that all claim in the patent should be…
Read More...

LENSAR and PDL BioPharma announced the completion of LENSAR's financial restructuring with a court-approved exit plan finalized on May 11, 2017.   As part of the plan, PDL will convert…
Read More...

Catalent Pharma Solutions announced that it will commercially manufacture Lexicon Pharmaceuticals, XERMELO following the FDA  approval at its Kansas City facility. XERMELO…
Read More...

INC Research and inVentiv Health announced that their Boards of Directors have  approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock…
Read More...

Proteon Therapeutics announced that FDA has awarded Breakthrough Therapy Designation to vonapanitase (investigational treatment) for increasing arteriovenous fistula secondary patency…
Read More...

Takeda Pharmaceutical signed contract with GammaDelta Therapeutics for collaboration to develop GammaDelta Therapeutics' novel T cell platform based on the unique properties of gamma…
Read More...